Effects of oligofluorine substitution on the mutagenicity of quinoline: A study with twelve fluoroquinoline derivatives

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 439, Issue 2, 1999, Pages 149-157

  Kato, Taka Aki ^a   Saeki, Ken Ichi ^a   Kawazoe, Yutaka ^a   Hakura, Atsushi ^b  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b Drug Safety Research Laboratories   (Japan)

Author keywords

Ames test; Fluoroquinoline; Mutagenicity; Quinoline; Salmonella typhimurium

Indexed keywords

FLUORINE DERIVATIVE; QUINOLINE; QUINOLINE DERIVATIVE;

ARTICLE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

ANIMALS; BIOTRANSFORMATION; FLUORINE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUTAGENS; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; SALMONELLA TYPHIMURIUM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033040692     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(98)00188-0     Document Type: Article

References (20)

1. M. Nagao, T. Yahagi, Y. Seino, T. Sugimura, N. Ito, Mutagenicities of quinoline and its derivatives, Mutat. Res. 42 (1977) 335-342.
2. K. Takahashi, M. Kamiya, Y. Sengoku, K. Kohda, Y. Kawazoe, Deprivation of the mutagenic property of quinoline: Inhibition of mutagenic metabolism by fluorine substitution, Chem. Pharm. Bull. 36 (1988) 4630-4633.
3. M. Kamiya, Y. Sengoku, K. Takahashi, K. Kohda, Y. Kawazoe, Antimutagenic structure modification of quinoline: fluorine-substitution at position-3, in: Y. Kuroda, D.M. Shankel, M.D. Waters (Eds.), Antimutagenesis and Anticarcinogenesis, Vol. II, Plenum, New York, 1990, pp. 441-446.
4. M. Tada, K. Takahashi, Y. Kawazoe, Binding of quinoline to nucleic acid in a subcellular microsomal system, Chem.-Biol. Interactions 29 (1980) 257-266.
5. M. Tada, K. Takahashi, Y. Kawazoe, Metabolites of quinoline, a hepatocarcinogen, in a subcellular microsomal system, Chem. Pharm. Bull. 30 (1982) 3834-3837.
6. K. Saeki, K. Takahashi, Y. Kawazoe, Metabolism of mutagenicity-deprived 3-fluoroquinoline: comparison with mutagenic quinoline, Biol. Pharm. Bull. 16 (1993) 232-234.
7. K. Saeki, H. Kawai, Y. Kawazoe, A. Hakura, Dual stimulatory and Inhibitory effects of fluorine-substitution on mutagenicity: an extension of the enamine epoxide theory for activation of the quinoline nucleus, Biol. Pharm. Bull. 20 (1997) 646-650.
8. E.J. LaVoie, L. Tulley-Freiler, V. Bedenko, D. Hoffmann, Mutagenicity of substituted phenanthrenes in Salmonella typhimurium, Mutat. Res. 116 (1983) 91-102.
9. S.S. Hecht, E.J. LaVoie, V. Bedenko, L. Pingaro, S. Katayama, D. Hoffmann, D.J. Sardella, E. Boger, R.E. Lehr, Reduction of tumorigenicity and of dihydrodiol formation by fluorine substitution in the angular rings of dibenzo[a,i]-pyrene, Cancer Res. 41 (1981) 4341-4345.
10. E. Hubenman, T.J. Slag, Mutagenicity and tumor-initiating activity of fluorinated derivatives of 7,12-dimethylbenz[a]anthracene, Cancer Res. 39 (1979) 411-414.
11. L. Diamond, K. Chain, R.G. Harvey, J. DiGiovanni, Mutagenic activity of methyl- and fluoro-substituted derivatives of polycyclic aromatic hydrocarbons in a human hepatoma cell-mediated assay, Mutat. Res. 136 (1984) 65-72.
12. K. Saeki, M. Kadoi, Y. Kawazoe, M. Futakuchi, D. Tiwawech, T. Shirai, Modification of the carcinogenic property of quinoline, a hepatocarcinogen, by fluorine atom substitution: evaluation of carcinogenicity by a medium-term assay, Biol. Pharm. Bull. 20 (1997) 40-43.
13. Y. Miyata, K. Saeki, Y. Kawazoe, M. Hayashi, T. Sofuni, T. Suzuki, Antimutagenic structural modification of quinoline assessed by an in vivo mutagenesis assay using lacZ transgenic mice, Mutat. Res. 414 (1998) 165-169.
14. M.H. Palmer, The Skraup reaction: formation of 5- and 7-substituted quinolines, J. Chem. Soc. (1962) pp. 3645-3652.
15. H. Gerson, M.W. McNeil, R. Parmegiani, P.K. Godfrey, Secondary mechanisms of antifungal action of substituted 8-quinolinols.3: 5,7,8-substituted quinolines, J. Med. Chem. 15 (1972) 105-106.
16. Y. Hamada, M. Sugiura, Studies on nitrogen-containing heterocyclic compounds. XXVII: Syntheses of 3-bromo methylquinolines, Yakugaku Zasshi 98 (1978) 1-10.
17. B.N. Ames, J. McCann, E. Yamazaki, Methods for detecting carcinogens and mutagens with the Salmonella/ mammalian-microsome mutagenicity test, Mutat. Res. 31 (1975) 347-363.
18. K. Takahashi, T. Kaiya, Y. Kawazoe, Structure-mutagenicity relationship among aminoquinolines, aza-analogues of naphthylamine, and their N-acetyl derivatives, Mutat. Res. 187 (1987) 191-197.
19. A. Hakura, Y. Tsutsui, H. Mochida, Y. Sugihara, T. Mikami, F. Sagami, Mutagenicity of dihydroxybenzenes and dihydroxynaphthalenes for Ames Salmonella tester strains, Mutat. Res. 371 (1996) 293-299.
20. E.J. LaVoie, J. Defauw, M. Fealy, B.M. Way, C.A. McQueen, Genotoxicity of fluoroquinolines and methylquinolines, Carcinogenesis 12 (1991) 217-220.